Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Hamee
3134
River Eletec
6666
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -74.12%1.14B | 38.24%4.39B | 639.39%3.17B | -55.13%429M | 19.20%956M | -52.66%802M | 310.43%1.69B | -184.45%-805M | 65.70%-283M | -1,818.75%-825M |
Net profit before non-cash adjustment | -41.17%1.97B | 29.23%3.34B | 53.29%2.59B | 49.69%1.69B | -4.33%1.13B | -35.42%1.18B | 563.27%1.82B | 133.91%275M | -34.72%-811M | -80.24%-602M |
Total adjustment of non-cash items | -92.04%64M | 316.58%804M | 169.93%193M | -138.07%-276M | 409.83%725M | 41.50%-234M | -177.97%-400M | 24.51%513M | 5,785.71%412M | -87.93%7M |
-Depreciation and amortization | 42.53%1.14B | 31.30%797M | 22.63%607M | 36.36%495M | 69.63%363M | -23.02%214M | 33.65%278M | 5.05%208M | 30.26%198M | 100.00%152M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | ---- | --136M | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 213.74%207M | -196.30%-182M |
-Share of associates | 200.00%7M | ---7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | -1,208.33%-399M | 130.51%36M | 46.61%-118M | -1,104.55%-221M | --22M | --0 | -3,192.31%-856M | ---26M | --0 | --0 |
-Net exchange gains and losses | -280.28%-540M | 17.92%-142M | -9.49%-173M | -316.44%-158M | 329.41%73M | 54.55%17M | 191.67%11M | -131.58%-12M | 733.33%38M | ---6M |
-Other non-cash items | -216.67%-140M | 197.56%120M | 68.62%-123M | -246.82%-392M | 157.42%267M | -1,600.00%-465M | -90.96%31M | 1,206.45%343M | -172.09%-31M | 120.77%43M |
Changes in working capital | -480.43%-894M | -40.20%235M | 140.06%393M | -9.49%-981M | -540.00%-896M | -152.04%-140M | 116.88%269M | -1,474.14%-1.59B | 150.43%116M | -170.99%-230M |
-Change in receivables | -72.13%-976M | -3,880.00%-567M | 102.92%15M | -38.27%-513M | -45.49%-371M | -200.79%-255M | 148.47%253M | -638.14%-522M | 585.00%97M | -104.21%-20M |
-Change in inventory | 521.43%87M | 104.73%14M | 54.67%-296M | -335.33%-653M | -120.78%-150M | 3,538.10%722M | 98.01%-21M | -1,343.84%-1.05B | 23.96%-73M | -190.91%-96M |
-Change in prepaid assets | 144.21%42M | -136.12%-95M | --263M | ---- | ---- | ---- | ---- | ---- | ---- | ---45M |
-Change in payables | -124.51%-175M | 535.37%714M | -187.70%-164M | 254.55%187M | -346.94%-121M | 345.45%49M | 155.00%11M | -162.50%-20M | 190.91%32M | 110.28%11M |
-Change in accrued expense | ---- | ---- | ---- | ---- | --10M | ---- | ---- | ---- | ---- | ---- |
-Provision for loans, leases and other losses | -110.74%-16M | -36.60%149M | 11,850.00%235M | ---2M | ---- | -300.00%-40M | -600.00%-10M | --2M | ---- | ---- |
-Changes in other current assets | 620.00%144M | -94.12%20M | --340M | --0 | 57.14%-264M | -1,811.11%-616M | --36M | ---- | 175.00%60M | -627.27%-80M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -24.65%-177M | -39.22%-142M | -30.77%-102M | 11.36%-78M | -87.23%-88M | -9.30%-47M | -79.17%-43M | -118.18%-24M | -120.00%-11M | -5M |
Interest received (cash flow from operating activities) | 122.22%20M | -74.29%9M | 84.21%35M | -69.84%19M | -10.00%63M | 2.94%70M | 183.33%68M | -40.00%24M | 263.64%40M | -73.17%11M |
Tax refund paid | 22.96%-577M | -52.55%-749M | -506.17%-491M | 72.45%-81M | 8.13%-294M | -199.07%-320M | -435.00%-107M | -25.00%-20M | -148.48%-16M | 124.44%33M |
Other operating cash inflow (outflow) | -22.41%45M | 262.50%58M | -81.18%16M | 85M | 0 | -1M | 0 | 0.00%-1M | -200.00%-1M | 0.00%1M |
Operating cash flow | -87.48%446M | 35.40%3.56B | 603.21%2.63B | -41.29%374M | 26.39%637M | -68.73%504M | 295.16%1.61B | -204.80%-826M | 65.48%-271M | -1,644.44%-785M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 25.34%-2.88B | -88.82%-3.85B | -196.51%-2.04B | 48.27%-688M | 28.15%-1.33B | -1,979.78%-1.85B | 85.96%-89M | -768.49%-634M | -204.17%-73M | -105.88%-24M |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.41%-35M | 58.43%-37M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | 214.94%1B | ---870M | ---- | ---- |
Net investment product transactions | 254.85%463M | 69.18%-299M | -457.47%-970M | -137.34%-174M | 442.65%466M | 81.01%-136M | -528.07%-716M | -216.33%-114M | 130.72%98M | 25.81%-319M |
Advance cash and loans provided to other parties | 26.12%-215M | -377.05%-291M | 93.18%-61M | -87.42%-894M | -17.20%-477M | -347.25%-407M | ---91M | ---- | -269.03%-572M | 72.81%-155M |
Repayment of advance payments to other parties and cash income from loans | 38.35%184M | 166.00%133M | -89.34%50M | 1,703.85%469M | -78.15%26M | 77.61%119M | -17.28%67M | -62.33%81M | -38.04%215M | -8.92%347M |
Net changes in other investments | 36.40%-339M | -617.48%-533M | 156.91%103M | 20.26%-181M | -484.75%-227M | 171.08%59M | 25.23%-83M | -2,675.00%-111M | 98.59%-4M | -133.88%-283M |
Investing cash flow | 42.52%-2.78B | -65.94%-4.84B | -98.77%-2.92B | 4.80%-1.47B | 30.42%-1.54B | -2,618.18%-2.22B | 105.34%88M | -344.20%-1.65B | 21.23%-371M | -11.88%-471M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -75.46%1.23B | 52.86%5.02B | 7.40%3.28B | 855.00%3.06B | -88.59%320M | 486.82%2.81B | -64.75%478M | 2,725.00%1.36B | -90.46%48M | 8,483.33%503M |
Net common stock issuance | ---- | ---- | ---- | ---- | 199.75%392M | -257.83%-393M | -63.91%249M | 69,100.00%690M | -100.15%-1M | 11,450.00%681M |
Increase or decrease of lease financing | -11.04%-171M | -30.51%-154M | -15.69%-118M | -9.68%-102M | -1,760.00%-93M | ---5M | ---- | ---- | ---- | ---- |
Cash dividends paid | -40.13%-845M | -25.63%-603M | -1.05%-480M | -36.10%-475M | -50.43%-349M | -103.51%-232M | ---114M | ---- | ---- | ---- |
Net other fund-raising expenses | -1,200.00%-52M | 42.86%-4M | -102.55%-7M | 2,391.67%275M | 55.56%-12M | 95.67%-27M | -3,564.71%-623M | 86.18%-17M | -312.07%-123M | 52.63%58M |
Financing cash flow | -96.17%163M | 58.98%4.26B | -2.80%2.68B | 967.44%2.75B | -87.99%258M | 21,580.00%2.15B | -100.49%-10M | 2,769.74%2.03B | -106.12%-76M | 4,676.92%1.24B |
Net cash flow | ||||||||||
Beginning cash position | 47.10%9.37B | 65.09%6.37B | 77.51%3.86B | -22.80%2.17B | 18.17%2.82B | 446.56%2.38B | -49.54%436M | -45.83%864M | 0.19%1.6B | -17.17%1.59B |
Current changes in cash | -173.08%-2.17B | 24.53%2.98B | 43.92%2.39B | 356.57%1.66B | -248.39%-647M | -74.20%436M | 479.78%1.69B | 38.02%-445M | -5,028.57%-718M | 96.82%-14M |
Effect of exchange rate changes | 4.17%25M | -80.49%24M | 412.50%123M | 500.00%24M | 233.33%4M | 62.50%-3M | -150.00%-8M | 245.45%16M | -168.75%-11M | 142.11%16M |
Cash adjustments other than cash changes | -50.00%1M | --2M | ---- | 0.00%1M | --1M | ---- | 26,400.00%265M | 150.00%1M | -300.00%-2M | -99.32%1M |
End cash Position | -22.92%7.22B | 47.10%9.37B | 65.09%6.37B | 77.51%3.86B | -22.80%2.17B | 18.17%2.82B | 446.56%2.38B | -49.54%436M | -45.83%864M | 0.19%1.6B |
Free cash flow | -490.59%-3.58B | -203.06%-606M | 125.99%588M | -196.07%-2.26B | 43.95%-764M | -189.49%-1.36B | 204.32%1.52B | -285.22%-1.46B | 55.20%-379M | -531.34%-846M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |